Below 
                  is the text of an FDA announcement describing the committee 
                  and requirements for prospective members:
                
                  
                  FDA Seeking New Members with Hep C Experience
                  for its Antiviral Drugs Advisory Committee
                December 
                  4, 2010 -- The Food and Drug Administration (FDA), to assist 
                  in its mission to protect and promote the public health, uses 
                  49 committees and panels to obtain independent expert advice 
                  on scientific, technical, and policy matters. 
                  
                   FDA 
                  is seeking technically qualified medical/scientific consultants 
                  to serve as members of its Antiviral Drugs Advisory Committee 
                  for future panels to consider potential direct-acting antivirals 
                  (DAAs) for the treatment of hepatitis C -- specifically hepatologists 
                  or other medical doctors who treat a substantial number of hepatitis 
                  C patients. Consultants should have experience interpreting 
                  and analyzing detailed scientific data, and understand its public 
                  health significance.
FDA 
                  is seeking technically qualified medical/scientific consultants 
                  to serve as members of its Antiviral Drugs Advisory Committee 
                  for future panels to consider potential direct-acting antivirals 
                  (DAAs) for the treatment of hepatitis C -- specifically hepatologists 
                  or other medical doctors who treat a substantial number of hepatitis 
                  C patients. Consultants should have experience interpreting 
                  and analyzing detailed scientific data, and understand its public 
                  health significance. 
                  
                  Potential candidates will be required to provide detailed information 
                  concerning such matters as financial holdings, employment, and 
                  research grants and/or contracts to permit evaluation of possible 
                  sources of conflict of interest. Potential conflicts include, 
                  but may not be limited to: employment with a pharmaceutical 
                  sponsor, having financial interests or stock in pharmaceutical 
                  companies developing DAAs, participating as an investigator 
                  in pivotal studies of DAAs in development, being chair of a 
                  department in which colleagues are investigating a DAA, or receiving 
                  substantial amounts of reimbursement from DAA sponsors for consulting 
                  services or presentations. 
                  
                  Advisory Committee meetings are convened in the Washington DC 
                  metropolitan area, typically for two days twice a year. Committee 
                  members are appointed as Special Government Employees, and receive 
                  a salary for each meeting day as well as travel and per diem 
                  costs. 
                  
                  General information about FDA Advisory Committees can be found 
                  at www.fda.gov/AdvisoryCommittees/default.htm 
                  and information about membership can be found at www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/CommitteeMembership/default.htm. 
                  
                  
                  If you are a medical doctor meeting the criteria above, or would 
                  like to nominate a medical doctor with hepatitis C expertise, 
                  you may submit your information by: